107 related articles for article (PubMed ID: 18256973)
21. Charcot arthropathy risk elevation in the obese diabetic population.
Stuck RM; Sohn MW; Budiman-Mak E; Lee TA; Weiss KB
Am J Med; 2008 Nov; 121(11):1008-14. PubMed ID: 18954849
[TBL] [Abstract][Full Text] [Related]
22. [Diabetic (Charcot type) neuroarthropathy].
TEMESIO P; CRESPODI ; GOMENSORO JB
Sem Med; 1963 Feb; 122():273-80. PubMed ID: 13980517
[No Abstract] [Full Text] [Related]
23. Levels of endothelial nitric oxide synthase and calcitonin gene-related peptide in the Charcot foot: a pilot study.
La Fontaine J; Harkless LB; Sylvia VL; Carnes D; Heim-Hall J; Jude E
J Foot Ankle Surg; 2008; 47(5):424-9. PubMed ID: 18725122
[TBL] [Abstract][Full Text] [Related]
24. Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.
Satoh M; Oyama N; Yamada H; Nakamura K; Kaneko F
J Dermatol; 2008 Mar; 35(3):168-71. PubMed ID: 18346261
[No Abstract] [Full Text] [Related]
25. Efficacy of alendronate in the treatment of the SAPHO syndrome.
Fioravanti A; Cantarini L; Burroni L; Mazzei MA; Volterrani L; Galeazzi M
J Clin Rheumatol; 2008 Jun; 14(3):183-4. PubMed ID: 18525442
[No Abstract] [Full Text] [Related]
26. Medical treatment of otosclerosis: rationale for use of bisphosphonates.
Brookler K
Int Tinnitus J; 2008; 14(2):92-6. PubMed ID: 19205157
[TBL] [Abstract][Full Text] [Related]
27. [Alendronate].
Okazaki R
Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
[TBL] [Abstract][Full Text] [Related]
28. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Rossi CM; Di Comite G
N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
[No Abstract] [Full Text] [Related]
29. Long-term effects of local pretreatment with alendronate on healing of replanted rat teeth.
Komatsu K; Shimada A; Shibata T; Shimoda S; Oida S; Kawasaki K; Nifuji A
J Periodontal Res; 2008 Apr; 43(2):194-200. PubMed ID: 18302622
[TBL] [Abstract][Full Text] [Related]
30. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
Eiken PA; Abrahamsen B
Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
[No Abstract] [Full Text] [Related]
31. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R; Lamy O; Peytremann-Bridevaux I
Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
[No Abstract] [Full Text] [Related]
32. Medical image. A sequel of deranged metabolic control. Diabetes mellitus.
Kumar N; Cheung YC; Varughese GI; Benn JJ; Willis AC
N Z Med J; 2008 Jan; 121(1268):U2900. PubMed ID: 18256715
[No Abstract] [Full Text] [Related]
33. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.
Richard JL; Almasri M; Schuldiner S
Diabetologia; 2012 May; 55(5):1258-64. PubMed ID: 22361982
[TBL] [Abstract][Full Text] [Related]
34. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Babb RR
N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
[No Abstract] [Full Text] [Related]
35. Nodular scleritis following alendronate therapy.
Tabbara KF
Ocul Immunol Inflamm; 2008; 16(3):99-101. PubMed ID: 18569796
[TBL] [Abstract][Full Text] [Related]
36. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
37. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
38. Alendronate is effective to treat bone loss in renal transplantation recipients.
Lan G; Peng L; Xie X; Peng F; Wang Y; Yu S
Transplant Proc; 2008 Dec; 40(10):3496-8. PubMed ID: 19100422
[TBL] [Abstract][Full Text] [Related]
39. Iontophoresis significantly increases the trans-dentinal delivery of osteoprotegerin, alendronate, and calcitonin.
Kitchens JA; Schwartz SA; Schindler WG; Hargreaves KM
J Endod; 2007 Oct; 33(10):1208-11. PubMed ID: 17889691
[TBL] [Abstract][Full Text] [Related]
40. [Patient compliance program aids therapy success].
MMW Fortschr Med; 2009 Mar; 151(11):47. PubMed ID: 19469207
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
